Outcomes in systemic sclerosis patients hospitalized with COVID-19: Insight from the National Inpatient Sample.

COVID-19 patients with systemic sclerosis had worse outcomes (i.e. higher composite endpoint of major adverse events) than those without systemic sclerosis. Further studies are needed to establish a better understanding of the relationship between COVID-19 and systemic sclerosis.